MDimune Signs Research Agreement with YiPSCELL to Develop iPSC-Based BioDrone® Therapeutics

0
13
MDimune announced a joint research agreement with YiPSCELL to develop BioDrone® Platform therapeutics based on iPSCs.
[MDimune (EIN Presswire, Inc.)]
Press Release